Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Justin W. Yorke currently holds 38,749 shares of Processa Pharmaceuticals, Inc. (PCSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Justin W. Yorke has been a net seller of PCSA stock. They have purchased $21.5K and sold $208.0K worth of shares.
Justin W. Yorke's most recent insider trade was on Jul 26, 2026, when they sold 33,500 shares at $0.00 per share.
Justin W. Yorke serves as Executive at Processa Pharmaceuticals, Inc. (PCSA). They have executed 27 insider transactions totaling $229.5K over their tenure at the company.
Justin W. Yorke holds the position of Executive at Processa Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Justin W. Yorke has shown a selling trading pattern, with $21.5K in total purchases and $208.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Justin W. Yorke was on Apr 14, 2021, when they sold $91.4K worth of PCSA shares. This transaction involved 9,700 shares at $9.42 per share.
Justin W. Yorke currently owns 38,749 shares of Processa Pharmaceuticals, Inc. (PCSA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Justin W. Yorke's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Justin W. Yorke has 27 Form 4 filings on record as an insider at Processa Pharmaceuticals, Inc..
Set alerts for Justin W. Yorke and 40,000+ other insiders.